Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 84,069 | 81,803 | 73,463 | 76,214 | 71,743 |
| Cost of Goods | 48,557 | 47,368 | 45,117 | 44,365 | 44,972 |
| Gross Profit | 35,512 | 34,435 | 28,346 | 31,849 | 26,771 |
| Operating Expenses | 51,419 | 54,516 | 48,258 | 48,349 | 44,822 |
| Operating Income | -15,350 | -19,713 | -19,795 | -16,135 | -17,079 |
| Interest Expense | 28 | 17 | 14 | 40 | 14 |
| Other Income | 7,869 | -1,789 | 8,086 | 8,138 | -1,439 |
| Pre-tax Income | -7,509 | -21,519 | -11,723 | -8,037 | -18,532 |
| Income Tax | -683 | -2,263 | 176 | -1,847 | -3,838 |
| Net Income Continuous | -6,826 | -19,256 | -11,899 | -6,190 | -14,694 |
| Minority Interests | -218 | -299 | -369 | -302 | -46 |
| Net Income | $-6,608 | $-18,957 | $-11,530 | $-5,888 | $-14,648 |
| EPS Basic Total Ops | -0.21 | -0.62 | -0.37 | -0.19 | -0.48 |
| EPS Basic Continuous Ops | -0.22 | -0.63 | -0.39 | -0.20 | -0.48 |
| EPS Diluted Total Ops | -0.21 | -0.62 | -0.37 | -0.19 | -0.48 |
| EPS Diluted Continuous Ops | -0.22 | -0.63 | -0.39 | -0.20 | -0.48 |
| EPS Diluted Before Non-Recurring Items | -0.16 | -0.25 | -0.30 | -0.23 | -0.05 |
| EBITDA(a) | $-483 | $-15,065 | $-15,534 | $-21,561 | $-2,421 |